journal article·2021-06-22

Synergistic Enhancement of Fluorescence and Magnetic Resonance Signals Assisted by Albumin Aggregate for Dual-Modal Imaging

Lirong Wang, Qing Wan, Rongyuan Zhang, Bo Situ, Kaiyuan Ni, Jinhao Gao, Xing Feng, Pengfei Zhang, Zhiming Wang, Anjun Qin, Ben Zhong Tang

ACS Nano· Volume 15· Issue 6
Publisher page

Abstract

Dual-modal fluorescence and magnetic resonance imaging (FLI/MRI) is important for the early diagnosis of malignant tumors. However, facile and opportune strategies to synergistically enhance fluorescence intensity and magnetic resonance (MR) contrast have rarely been reported. Herein, we present a facile strategy using albumin aggregates (AAs) to synergistically enhance the fluorescence intensity by aggregation-induced emission (AIE) and MR contrast with prolonged rotational correlation time (τR) of Gd(III) chelates and the diffusion correlation time (τD) of surrounding water molecules. The amphiphilic dual-modal FLI/MRI probe of NGd was facilely loaded into albumin pockets and then formed AAs to generate a supramolecular structure of NGd-albumin aggregates (NGd-AAs), which show excellent biocompatibility and biosafety, and exhibit superior fluorescence quantum yield and r1 over NGd with 6- and 8-fold enhancement, respectively. Moreover, compared with the clinical MRI contrast agent Gd-DOTA, r1 of NGd-AAs showed a 17-fold enhancement. Therefore, NGd-AAs successfully elicited high-performance dual-modal FLI/MRI in vitro and in vivo and high contrast MR signals were observed in the liver and tumor after intravenous injection of NGd-AAs at a dosage of 6 μmol Gd(III)/kg body weight. This generic and feasible strategy successfully realized a synergistic effect for dual-modal FLI/MRI.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Carbon and Quantum Dots Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, AIE Institute, Center for Aggregation-Induced Emission, South China University of Technology, Guangzhou 510640, China

Department of Urology, The First Affiliated Hospital of Soochow University, 188 Shizi Road, Suzhou 215006, China

Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, United States

Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China

School of Material and Energy, Guangdong University of Technology, Guangzhou 510006, China

Guangdong Key Laboratory of Nanomedicine, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, CAS Key Laboratory of Health Informatics, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

Shenzhen Institute of Molecular Aggregate Science and Engineering, School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Boulevard, Longgang District, Shenzhen City, Guangdong 518172, China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province · Innovation and Technology Commission of Hong Kong · National Key Research and Development Program of China

References (40)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.1152/physrev.00049.201010.1152/physrev.00049.2010 ↗
3. 10.1002/adma.20170365110.1002/adma.201703651 ↗
4. 10.1021/nl060765q10.1021/nl060765q ↗
5. 10.1021/jacs.9b0364910.1021/jacs.9b03649 ↗
6. 10.1021/ic402233g10.1021/ic402233g ↗
7. 10.1021/jacs.5b0450910.1021/jacs.5b04509 ↗
8. 10.1021/jacs.8b1337610.1021/jacs.8b13376 ↗
9. 10.1021/acs.chemrev.8b0036310.1021/acs.chemrev.8b00363 ↗
10. 10.1038/nnano.2010.20310.1038/nnano.2010.203 ↗
11. 10.1016/j.canlet.2014.06.00110.1016/j.canlet.2014.06.001 ↗
12. 10.1039/C5NR08402D10.1039/C5NR08402D ↗
13. 10.1039/C7NR01134B10.1039/C7NR01134B ↗
14. 10.1007/s11426-018-9291-910.1007/s11426-018-9291-9 ↗
15. 10.1021/acs.accounts.9b0030510.1021/acs.accounts.9b00305 ↗
16. 10.1039/C9QM00156E10.1039/C9QM00156E ↗
17. 10.1002/anie.20200084510.1002/anie.202000845 ↗
18. 10.1039/C9CS00495E10.1039/C9CS00495E ↗
19. 10.1021/am502282f10.1021/am502282f ↗
20. 10.1016/j.jconrel.2008.05.01010.1016/j.jconrel.2008.05.010 ↗
21. 10.1016/j.bbagen.2013.04.02310.1016/j.bbagen.2013.04.023 ↗
22. 10.1039/C5CS00158G10.1039/C5CS00158G ↗
23. 10.1002/adhm.20180091310.1002/adhm.201800913 ↗
24. 10.1021/ar800220p10.1021/ar800220p ↗
25. 10.1021/jm400017710.1021/jm4000177 ↗
26. 10.1038/s41467-019-10056-910.1038/s41467-019-10056-9 ↗
27. 10.1002/adfm.20190271710.1002/adfm.201902717 ↗
28. 10.1002/adfm.20170619610.1002/adfm.201706196 ↗
29. 10.1021/ja901875v10.1021/ja901875v ↗
30. 10.1021/nn305991e10.1021/nn305991e ↗
31. 10.1002/smll.20180161210.1002/smll.201801612 ↗
32. 10.1002/adma.20120316910.1002/adma.201203169 ↗
33. 10.1007/978-1-60761-609-2_310.1007/978-1-60761-609-2_3 ↗
34. 10.1002/adhm.20190122310.1002/adhm.201901223 ↗
35. 10.1021/nn102430310.1021/nn1024303 ↗
36. 10.1016/B978-0-12-819943-5.00003-810.1016/B978-0-12-819943-5.00003-8 ↗
37. 10.2217/17435889.3.5.70310.2217/17435889.3.5.703 ↗
38. 10.1039/b714539j10.1039/b714539j ↗
39. 10.1021/acsami.6b0080610.1021/acsami.6b00806 ↗
40. 10.1016/j.foodchem.2011.02.04010.1016/j.foodchem.2011.02.040 ↗